Natural Immune Systems

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Natural Immune Systems sits in the top decile of US sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count).

17 total trials 5 currently recruiting 10 completed early-phase tilt top decile by trial count

Natural Immune Systems: 17 sponsored US clinical trials, 5 recruiting.

Natural Immune Systems sponsors 17 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 10 completed. 0 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Immune Surveillance, with 3 trials.

Top-decile sponsor footprint

Natural Immune Systems ranks in the top decile of sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

A 90/100

10 of 10 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

17 total, page 1 of 1

RECRUITING NA

Rapid Effects of a Biofield Patch on Antioxidant Status and Cellular Energy

NCT07314359

RECRUITING NA

Clinical Trial on Rapid Immune Modulating Effects

NCT07206407

RECRUITING NA

Rapid Response of Stem Cells and Immune Cells for Efficacy

NCT07127705

RECRUITING NA

Acute Immune Modulation by Probiotic Strain

NCT06754228

RECRUITING NA

Clinical Trial: Rapid Immune Modulating Effects

NCT07195552

NOT YET RECRUITING NA

Longterm Effects of a Biofield Patch on Anxiety, Sleep, and Energy

NCT07353021

NOT YET RECRUITING NA

Acute Effects on Stem Cell Surveillance

NCT07341178

COMPLETED NA

Rapid Effects on Antioxidant Status, Immune Alertness, and Regenerative Activity

NCT07142720

COMPLETED NA

Effects of Topical Cream for Pain Relief

NCT05213052

COMPLETED NA

Acute Effects of an Herbal Tea on Immune Surveillance and Activation.

NCT04491461

COMPLETED NA

Evaluation of Hydration Status When Consuming Alkaline Water Compared to Reverse Osmosis Purified Water.

NCT04460846

COMPLETED NA

Evaluation of Activity Levels, Inflammatory Markers, and Overall Wellness.

NCT03619265

COMPLETED NA

Nutraceutical Support of Fatigue Reduction, Improved Physical, Mental & Cognitive Function and Mitochondrial Function

NCT04261881

COMPLETED NA

Golden Black Seed: Support of Metabolic Health and General Wellness.

NCT03643094

COMPLETED NA

CytoQuel: Clinical Documentation on Effects on Chronic Pain, Wellness, and Reduction of Inflammatory Markers

NCT03690609

COMPLETED Phase 1

Alkaline Ionized Water: Sports Recovery and Inflammation Management

NCT02748655

COMPLETED Phase 1

Efficacy of Jobelyn™ Consumption on Hemoglobin Levels in a Borderline Anemic Population

NCT01828060

Phase Distribution

PhaseTrial count
Phase 1 2

What is open in the Natural Immune Systems pipeline

5 recruiting of 17 indexed (29% open); 10 completed (59%).

Phase mix: 0 late (III/IV) vs 2 early (I/II) (early-phase heavy).

Top condition: Immune Surveillance (3 trials), 2 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Natural Immune Systems: open-pipeline peers nationwide

Peers matched on 17 registered trials and 29% open enrollment, not the therapeutic-area sidebar.

Natural Immune Systems sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 050100150 0%10%20%30%40% Total trials Recruiting share Natural Immune SystemsAchieve Life SciencesBioDelivery Sciences InternationalChugai PharmaceuticalConvaTecChildren's Hospital Los AngelesOno Pharmaceutical Co.Queen's Medical CenterInova Health Care Services
Natural Immune Systems sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Natural Immune Systems sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 17 trials (± recruiting share)

Sponsors near 29% open enrollment (± trial volume)

What to do with this Natural Immune Systems page

17 registered trials is a research-attention snapshot, not an endorsement of Natural Immune Systems or any single study.

  • 5 of Natural Immune Systems's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Immune Surveillance is the condition Natural Immune Systems studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Immune Surveillance trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Natural Immune Systems pipeline card: 17 registered trials from official public datasets.Report a data error.